PATENT CLAIM ANALYSIS

Application Number: 16223356
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "302000"]

Abstract:
Formulations for treating depressive disorders and methods for treating depressive disorders using gaboxadol or a pharmaceutically acceptable salt thereof are provided.

Claim (Index 7):
The method of  claim 1 , wherein the AUC 6-12  of the patient 6 hours after administration of the gaboxadol or pharmaceutically acceptable salt thereof is less than 75% of the administered dose.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15873425', '16056754', '15191068', '16157653', '15680417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7585048775235036
- 35 USC 102 Novelty (BERT): 0.4833512995741544
- Combined Prediction Score: 0.7309895197285686
- Mean Citation Score: 251.334538
- Max Citation Score: 258.7443
- Similarity Product: 257.4017679577768

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test